Viewing StudyNCT00696917



Ignite Creation Date: 2024-05-05 @ 7:34 PM
Last Modification Date: 2024-10-26 @ 9:50 AM
Study NCT ID: NCT00696917
Status: COMPLETED
Last Update Posted: 2008-06-13
First Post: 2008-06-11

Brief Title: Safety and Immunogenicity of 3 Lots of GSK Biologicals HBV-MPL Vaccine and Engerix-B in Healthy Volunteers 15y
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 1999-04
Start Date Type: None
Primary Completion Date: 2000-02
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2008-06-11
First Submit QC Date: June 11 2008
Study First Post Date: 2008-06-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-06-11
Last Update Post Date: 2008-06-13
Last Update Post Date Type: ESTIMATED